WHO Reports Lowered Threat Level of COVID-19; What Does it Mean for Testing?

Three years and more than seven million casualties later, the COVID-19 pandemic is officially no longer a global health emergency, according to a recent statement by the World Health Organization (WHO). Dr. Tedros Adhanom Ghebreyesus, director general of WHO, announced COVID-19’s less severe designation in early May, though the decision had been carefully considered for […]

SDi Releases Flagship Market Research Report on Analytical and Life Science Instruments: The Global Assessment Report

The definitive market reference tool for the analytical and life science instrumentation industry is officially here. The SDi Global Assessment Report 2023 is the latest edition in the bestselling market research report series published annually by Strategic Directions International (SDi), the leading business intelligence firm focused on analytical and life science instruments. SDi is a […]

Despite Declines, COVID-19 Still a Large IVD Market

When a market declines in momentum, it’s easy to forget that it still contributes to the overall market. This is the case with COVID-19. Testmakers are separating revenues to be sure investors know the parts of their business growing and declining and what part is related to the now-endemic disease. However, this belies the fact […]

Single Cell Genomics Market Reaches $1 Billion

After seeing products first introduced roughly a decade ago, the field of single cell genomics has experienced rapidly growing adoption in the last few years as evidenced by the market’s recent sales. In 2022, the total single cell market had sales of more than $1 billion and is forecast to grow exponentially in coming years, […]

Six Trends to Watch in POC-IVD

Point of care IVD sales reached 45 billion dollars in 2022.  This includes instruments – permanent and disposable, and associated reagents and supplies.   Kalorama Information’s latest report details this:  https://kaloramainformation.com/product/the-worldwide-market-for-point-of-care-poc-diagnostic-tests-10th-edition/ Point of care covers a variety of tests – some performed in a lab, some in a doctor’s office, some in a patient’s home […]

Hematology Grows, Driven by Decentralization

The global market for hematology testing, inclusive of analyzers/instruments and reagents, is valued at $5,655 million in 2022. This includes all commercial laboratory and hospital-based products, some research use products used in clinical laboratories, and OTC product sales (not test services). This is according to Kalorama’s latest on hematology IVD. The report indicates that decentralized […]

3 Trends Shaping Global $124 Billion In Vitro Diagnostic (IVD) Market

There’s no debate, in vitro diagnostics (IVDs) comprise a dynamic international industry with years of growth still ahead. The market already has more than $124 billion in worldwide sales and a presence in more than 20 key healthcare and medical segments ranging from molecular microbiology to infectious disease immunoassays to point-of-care (POC) to clinical chemistry. […]

New AACC Guidance Advises Cervical Cancer Testing Strategies for Clinicians and Labs

Cancer by the Numbers There have been notable advances in cancer treatment, yet cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry, according to World Cancer Research Fund International data cited by Kalorama Information in the report Precision Cancer Therapeutics […]

The First Step in Market-Sizing the Molecular Point of Care Market: Defining What it is.

To establish a market size and forecast for molecular point of care systems, it’s necessary to understand what it is that is being measured. If a market for every dollar earned by selling any system that “could be used” in molecular point of care was established, the market would be much larger and have much […]

Brazil and Mexico Lead IVD Investments in Latin America